Navigator Medicines
Latest round
- Series A
Last raised
- Aug 2024
Total raised
- $50M
Investors
- 2
About Navigator Medicines
Founded in 2024 and based in New Jersey, US, Navigator Medicines, Inc. offers immune regulation and treatments for autoimmune diseases. The company’s product pipeline includes a biologics immune portfolio, NAV-240, formerly known as IMB101, a clinical-stage bispecific antibody designed to target OX40L and TNFa. The product improves health by addressing two distinct yet interrelated mechanisms of inflammation and immune response.
Who invested in Navigator Medicines
2 investors across 1 round
See all investors in Navigator Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 23, 2024
Amount
$50M
Investors
Questions about Navigator Medicines
Who invested in Navigator Medicines?
Navigator Medicines has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Navigator Medicines raised?
Navigator Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Navigator Medicines last raise money?
Navigator Medicines's most recent round on record is a Series A, in Aug 2024.
What does Navigator Medicines do?
Founded in 2024 and based in New Jersey, US, Navigator Medicines, Inc.
Where is Navigator Medicines headquartered?
Navigator Medicines is headquartered in Scotch Plains, US.
Which VCs invest in companies like Navigator Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Navigator Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Navigator Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.